CordovaCann Corp. (CSE: CDVA)
CDVA trades on the Canadian Securities Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for CDVA.CN, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | CDVA on the Canadian Securities Exchange |
| Yahoo symbol | CDVA.CN |
| Sector | Life Sciences, Drug Manufacturers—Specialty & Generic |
| Headquarters | Ontario |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | Not on the TMX list |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001168981 |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | 0.0% |
| 1 week | -60.0% |
| 1 month | -60.0% |
| 3 months | -60.0% |
| 6 months | -50.0% |
| Year to date | -66.7% |
| 1 year | -75.0% |
| From 52-week high | -87.5% |
| 52-week range | C$0.0100 to C$0.0800 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
73 documents in 6 types. Each title links to the document at its source.
MD&A (18)
| Document | Type | Filed |
|---|---|---|
| Interim Financial Statements and MD&A for the period ended March 31, 2024 Period 2024-03-31 | MD&A (interim) (6-K) | 2026-09-21 |
| Interim Financial Statements and MD&A for the period ended December 31, 2023 Period 2023-12-31 | MD&A (interim) (6-K) | 2026-09-21 |
| Interim Financial Statements and MD&A for the period ended September 30, 2023 Period 2023-09-30 | MD&A (interim) (6-K) | 2026-09-21 |
| Interim Financial Statements and MD&A for the period ended March 31, 2023 Period 2023-03-31 | MD&A (interim) (6-K) | 2026-09-21 |
Material change report (2)
| Document | Type | Filed |
|---|---|---|
| MATERIAL CHANGE REPORT | Material change report (6-K) | 2026-09-21 |
| MATERIAL CHANGE REPORT | Material change report (6-K) | 2026-09-21 |
News release (23)
| Document | Type | Filed |
|---|---|---|
| NEWS RELEASE | News release (6-K) | 2026-09-21 |
| NEWS RELEASE | News release (6-K) | 2026-09-21 |
| NEWS RELEASE | News release (6-K) | 2026-09-21 |
| NEWS RELEASE | News release (6-K) | 2026-09-21 |
Annual report (3)
| Document | Type | Filed |
|---|---|---|
| FORM 20-F Period 2025-06-30 | Annual report (20-F) (20-F) | 2026-02-02 |
| FORM 20-F/A Period 2024-06-30 | Annual report (20-F) (20-F/A) | 2025-04-28 |
| FORM 20-F Period 2024-06-30 | Annual report (20-F) (20-F) | 2024-12-16 |
Certification (9)
| Document | Type | Filed |
|---|---|---|
| CERTIFICATION Period 2025-06-30 | Certification (SOX 302/906) (20-F) | 2026-02-02 |
| CERTIFICATION Period 2025-06-30 | Certification (SOX 302/906) (20-F) | 2026-02-02 |
| CERTIFICATION Period 2025-06-30 | Certification (SOX 302/906) (20-F) | 2026-02-02 |
| CEO Period 2024-06-30 | Certification (SOX 302/906) (20-F/A) | 2025-04-28 |
Other (18)
| Document | Type | Filed |
|---|---|---|
| CONSENT DNTW Period 2025-06-30 | Consent (20-F) | 2026-02-02 |
| CONSENT Period 2025-06-30 | Consent (20-F) | 2026-02-02 |
| CONSENT DNTW TORONTO LLP Period 2024-06-30 | Consent (20-F/A) | 2025-04-28 |
| CONSENT KRESTON GTA LLP Period 2024-06-30 | Consent (20-F/A) | 2025-04-28 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2022-04-21 | Equity, Option To Acquire, Security To Be Acquired, Other | US$1.7M | US$3.3M | SEC EDGAR |
| 2021-08-31 | Equity, Option To Acquire, Security To Be Acquired, Other | US$524K | US$1.3M | SEC EDGAR |
| 2021-04-01 | Equity | US$1.1M | US$1.1M | SEC EDGAR |
| 2021-03-16 | Equity, Other | US$1.4M | US$1.4M | SEC EDGAR |
| 2020-09-02 | Equity, Other | US$502K | US$502K | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| NAV | NAVCO Pharmaceuticals Inc. | TSXV | C$285K | 0.0% | 0.0% |
| EVMT | Evome Medical Technologies Inc. | TSXV | C$301K | 0.0% | 0.0% |
| ARC | ARCpoint Inc. | TSXV | C$332K | 0.0% | 0.0% |
| VXL | Vaxil Bio Ltd. | TSXV | C$398K | -24.1% | -35.3% |
| WAVE | Waverley Pharma Inc. | TSXV | C$540K | +100.0% | 0.0% |
The app has the price chart, every filing, private raises and the full peer set for CDVA.
Open in the app